Pulmonary Wegener's granulomatosis: changes at follow-up CT

被引:21
|
作者
Attali, P
Begum, R
Ben Romdhane, H
Valeyre, D
Guillevin, L
Brauner, MW
机构
[1] Univ Paris 13, Hop Avicenne, Dept Radiol, F-93009 Bobigny, France
[2] Univ Paris 13, Hop Avicenne, Dept Pneumol, F-93009 Bobigny, France
[3] Univ Paris 13, Hop Avicenne, Dept Internal Med, F-93009 Bobigny, France
关键词
Wegener's granulomatosis; lung diseases; CT;
D O I
10.1007/s003300050506
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The objective of this study was to assess the reversibility of pulmonary lesions in Wegener's granulomatosis using serial CT. We reviewed the follow-up CT scans of ten treated patients with confirmed Wegener's granulomatosis. The delay between the first evaluation before treatment and the second, on patients in clinical and biological remission, ranged from 6 to 54 months (mean 20.5 months). Follow-up CT showed a decrease in the extent of disease in all cases. Lesions disappeared completely, without scarring, in 4 of 4 ground-glass opacities, 25 of 36 nodules, and 4 of 9 pulmonary consolidations; they disappeared with residual scarring in 8 of 8 masses, 3 of 9 pulmonary consolidations, and 2 of 36 nodules. The majority of lesions disappear without scarring. Residual fibrosis may follow the occurence of masses and pulmonary consolidation. Computed tomography permits assessment of cicatricial lesions.
引用
收藏
页码:1009 / 1013
页数:5
相关论文
共 50 条
  • [21] Lessons learnt in the management of Wegener's granulomatosis: long-term follow-up of 60 patients
    Sproson, E. L.
    Jones, N. S.
    Al-Deiri, M.
    Lanyon, P.
    RHINOLOGY, 2007, 45 (01) : 63 - 67
  • [22] Induction of remission with infliximab in therapy-refractory Wegener's granulomatosis -: Follow-up of six patients
    Lamprecht, P
    Arbach, O
    Voswinkel, J
    Lilienthal, T
    Nölle, B
    Heller, M
    Gause, A
    Gross, WL
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (37) : 1876 - 1880
  • [23] Pulmonary cavernae in Wegener's granulomatosis
    Schwenger, V
    Morath, C
    Kihm, LP
    Andrassy, K
    Zeier, M
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (03) : 818 - 818
  • [24] FOLLOW-UP OF PULMONARY NODULES BY CT
    ROBERTSON, EM
    CLINICAL RADIOLOGY, 1992, 46 (01) : 70 - 70
  • [25] Rhinologic changes in Wegener's granulomatosis
    Lloyd, G
    Lund, VJ
    Beale, T
    Howard, D
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2002, 116 (07): : 565 - 569
  • [26] Induction of remission with infliximab in refractory Wegener's granulomatosis (WG) - An update on the follow-up of 6 patients.
    Lamprecht, P
    Arbach, O
    Voswinkel, J
    Lilienthal, T
    Noelle, B
    Heller, M
    Gause, A
    Gross, WL
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S186 - S187
  • [27] Analysis of factors predictive of survival based on 49 patients with systemic Wegener's granulomatosis and prospective follow-up
    Mahr, A
    Girard, T
    Agher, R
    Guillevin, L
    RHEUMATOLOGY, 2001, 40 (05) : 492 - 498
  • [28] Pulmonary Wegener's Granulomatosis Misdiagnosed As Malignancy?
    Campainha, S.
    Neves, S.
    Tavares, V.
    Goncalves, M.
    Casteloes, P.
    Fernandes, P.
    Marinho, A.
    Brito, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [29] Pulmonary artery involvement in Wegener's granulomatosis
    Clark, T
    Hoffman, GS
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2003, 21 (06) : S124 - S126
  • [30] Pulmonary fibrosis as a presentation of Wegener's granulomatosis
    Ketata, W.
    Msaad, S.
    Gharsalli, H.
    Kammoun, K.
    Abid, T.
    Mrabet, S.
    Makni, S.
    Boudawara, T.
    Ayoub, A.
    REVUE DES MALADIES RESPIRATOIRES, 2009, 26 (09) : 981 - 984